tiprankstipranks
Cardinal Health (GB:0HTG)
LSE:0HTG
UK Market
0HTG
Cardinal Health
RESEARCH TOOLSreports

Cardinal Health (0HTG) Share Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

0HTG Analyst Ratings

Strong Buy
15Ratings
Strong Buy
13 Buy
2 Hold
0 Sell
Based on 15 analysts giving stock ratings to
Cardinal
Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

0HTG Stock 12 Month Forecast

Average Price Target

$270.00
▲(17.05% Upside)
Based on 15 Wall Street analysts offering 12 month price targets for Cardinal Health in the last 3 months. The average price target is $270.00 with a high forecast of $292.00 and a low forecast of $250.00. The average price target represents a 17.05% change from the last price of $230.68.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"146":"$146","293":"$293","182.75":"$182.8","219.5":"$219.5","256.25":"$256.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":292,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$292.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":270,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$270.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":250,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$250.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[146,182.75,219.5,256.25,293],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,230.23,234.98153846153846,239.7330769230769,244.48461538461538,249.23615384615385,253.9876923076923,258.73923076923074,263.4907692307692,268.2423076923077,272.99384615384616,277.74538461538464,282.49692307692305,287.2484615384615,{"y":292,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,230.23,233.28923076923076,236.34846153846152,239.4076923076923,242.46692307692308,245.52615384615385,248.5853846153846,251.64461538461538,254.70384615384614,257.76307692307694,260.8223076923077,263.88153846153847,266.9407692307692,{"y":270,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,230.23,231.7507692307692,233.27153846153846,234.79230769230767,236.31307692307692,237.83384615384614,239.35461538461539,240.8753846153846,242.39615384615385,243.91692307692307,245.43769230769232,246.95846153846153,248.47923076923075,{"y":250,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":154.938,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":147.27,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":156.157,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":190.117,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":208.372,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":206.093,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":216.634,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":227.941,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":212.159,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":193.56,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":194.587,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":238.24,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":230.23,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$292.00Average Price Target$270.00Lowest Price Target$250.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on GB:0HTG
Ryan Halsted
RBC Capital
RBC Capital
$276
Buy
19.65%
Upside
Initiated
08/19/26
Cardinal Health initiated with an Outperform at RBC CapitalCardinal Health initiated with an Outperform at RBC Capital
Barclays Analyst forecast on GB:0HTG
Glen Santangelo
Barclays
Barclays
$275
Buy
19.21%
Upside
Reiterated
08/18/26
Analysts' Top Healthcare Picks: BioMarin Pharmaceutical (BMRN), Immatics (IMTX)
J.P. Morgan Analyst forecast on GB:0HTG
Lisa Gill
J.P. Morgan
J.P. Morgan
$260
Hold
12.71%
Upside
Reiterated
08/17/26
Analysts Offer Insights on Healthcare Companies: Silence Therapeutics (NASDAQ: SLN), Cardinal Health (NYSE: CAH) and Allogene Therapeutics (NASDAQ: ALLO)
Deutsche Bank Analyst forecast on GB:0HTG
George Hill
Deutsche Bank
Deutsche Bank
$223→$261
Hold
13.14%
Upside
Reiterated
08/13/26
Analysts Offer Insights on Healthcare Companies: Cullinan Management (NASDAQ: CGEM), Cardinal Health (NYSE: CAH) and QT Imaging Holdings (NASDAQ: QTI)
TD Cowen Analyst forecast on GB:0HTG
Charles Rhyee
TD Cowen
TD Cowen
$275→$280
Buy
21.38%
Upside
Assigned
08/13/26
Analysts' Top Healthcare Picks: Cardinal Health (CAH), Atea Pharmaceuticals (AVIR)
Mizuho Securities Analyst forecast on GB:0HTG
Steven Valiquette
Mizuho Securities
Mizuho Securities
$240→$250
Buy
8.38%
Upside
Reiterated
08/13/26
Analysts' Top Healthcare Picks: Neurocrine (NBIX), Aquestive Therapeutics (AQST)
Morgan Stanley Analyst forecast on GB:0HTG
Erin Wright
Morgan Stanley
Morgan Stanley
$265→$255
Buy
10.54%
Upside
Reiterated
08/12/26
Morgan Stanley Sticks to Its Buy Rating for Cardinal Health (CAH)
Evercore ISI Analyst forecast on GB:0HTG
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
$270
Buy
17.05%
Upside
Reiterated
08/12/26
Cardinal Health (CAH) Receives a Buy from Evercore ISI
Wells Fargo Analyst forecast on GB:0HTG
Stephen Baxter
Wells Fargo
Wells Fargo
$245→$277
Buy
20.08%
Upside
Assigned
08/12/26
Wells Fargo Gives a Buy Rating to Cardinal Health (CAH)
Citi Analyst forecast on GB:0HTG
Daniel Grosslight
Citi
Citi
$265→$280
Buy
21.38%
Upside
Reiterated
08/12/26
Citi Keeps Their Buy Rating on Cardinal Health (CAH)
Leerink Partners Analyst forecast on GB:0HTG
Michael Cherny
Leerink Partners
Leerink Partners
$275→$292
Buy
26.58%
Upside
Reiterated
08/11/26
Cardinal Health price target raised to $292 from $275 at LeerinkCardinal Health price target raised to $292 from $275 at Leerink
William Blair Analyst forecast on GB:0HTG
Ryan Daniels
William Blair
William Blair
―
Buy
―
Reiterated
08/11/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH), Axsome Therapeutics (NASDAQ: AXSM) and BridgeBio Pharma (NASDAQ: BBIO)
Bank of America Securities Analyst forecast on GB:0HTG
Allen Lutz
Bank of America Securities
Bank of America Securities
$260
Buy
12.71%
Upside
Reiterated
07/20/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Neogen (NASDAQ: NEOG) and Cardinal Health (NYSE: CAH)
UBS Analyst forecast on GB:0HTG
Kevin Caliendo
UBS
UBS
$260→$274
Buy
18.78%
Upside
Assigned
07/20/26
Cardinal Health price target raised to $274 from $260 at UBSCardinal Health price target raised to $274 from $260 at UBS
William O'Neil Analyst forecast on GB:0HTG
Unknown Analyst
William O'Neil
Not Ranked
William O'Neil
―
Buy
―
Initiated
06/12/26
Cardinal Health (CAH) Gets a Buy from William O'Neil
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on GB:0HTG
Ryan Halsted
RBC Capital
RBC Capital
$276
Buy
19.65%
Upside
Initiated
08/19/26
Cardinal Health initiated with an Outperform at RBC CapitalCardinal Health initiated with an Outperform at RBC Capital
Barclays Analyst forecast on GB:0HTG
Glen Santangelo
Barclays
Barclays
$275
Buy
19.21%
Upside
Reiterated
08/18/26
Analysts' Top Healthcare Picks: BioMarin Pharmaceutical (BMRN), Immatics (IMTX)
J.P. Morgan Analyst forecast on GB:0HTG
Lisa Gill
J.P. Morgan
J.P. Morgan
$260
Hold
12.71%
Upside
Reiterated
08/17/26
Analysts Offer Insights on Healthcare Companies: Silence Therapeutics (NASDAQ: SLN), Cardinal Health (NYSE: CAH) and Allogene Therapeutics (NASDAQ: ALLO)
Deutsche Bank Analyst forecast on GB:0HTG
George Hill
Deutsche Bank
Deutsche Bank
$223→$261
Hold
13.14%
Upside
Reiterated
08/13/26
Analysts Offer Insights on Healthcare Companies: Cullinan Management (NASDAQ: CGEM), Cardinal Health (NYSE: CAH) and QT Imaging Holdings (NASDAQ: QTI)
TD Cowen Analyst forecast on GB:0HTG
Charles Rhyee
TD Cowen
TD Cowen
$275→$280
Buy
21.38%
Upside
Assigned
08/13/26
Analysts' Top Healthcare Picks: Cardinal Health (CAH), Atea Pharmaceuticals (AVIR)
Mizuho Securities Analyst forecast on GB:0HTG
Steven Valiquette
Mizuho Securities
Mizuho Securities
$240→$250
Buy
8.38%
Upside
Reiterated
08/13/26
Analysts' Top Healthcare Picks: Neurocrine (NBIX), Aquestive Therapeutics (AQST)
Morgan Stanley Analyst forecast on GB:0HTG
Erin Wright
Morgan Stanley
Morgan Stanley
$265→$255
Buy
10.54%
Upside
Reiterated
08/12/26
Morgan Stanley Sticks to Its Buy Rating for Cardinal Health (CAH)
Evercore ISI Analyst forecast on GB:0HTG
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
$270
Buy
17.05%
Upside
Reiterated
08/12/26
Cardinal Health (CAH) Receives a Buy from Evercore ISI
Wells Fargo Analyst forecast on GB:0HTG
Stephen Baxter
Wells Fargo
Wells Fargo
$245→$277
Buy
20.08%
Upside
Assigned
08/12/26
Wells Fargo Gives a Buy Rating to Cardinal Health (CAH)
Citi Analyst forecast on GB:0HTG
Daniel Grosslight
Citi
Citi
$265→$280
Buy
21.38%
Upside
Reiterated
08/12/26
Citi Keeps Their Buy Rating on Cardinal Health (CAH)
Leerink Partners Analyst forecast on GB:0HTG
Michael Cherny
Leerink Partners
Leerink Partners
$275→$292
Buy
26.58%
Upside
Reiterated
08/11/26
Cardinal Health price target raised to $292 from $275 at LeerinkCardinal Health price target raised to $292 from $275 at Leerink
William Blair Analyst forecast on GB:0HTG
Ryan Daniels
William Blair
William Blair
―
Buy
―
Reiterated
08/11/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH), Axsome Therapeutics (NASDAQ: AXSM) and BridgeBio Pharma (NASDAQ: BBIO)
Bank of America Securities Analyst forecast on GB:0HTG
Allen Lutz
Bank of America Securities
Bank of America Securities
$260
Buy
12.71%
Upside
Reiterated
07/20/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Neogen (NASDAQ: NEOG) and Cardinal Health (NYSE: CAH)
UBS Analyst forecast on GB:0HTG
Kevin Caliendo
UBS
UBS
$260→$274
Buy
18.78%
Upside
Assigned
07/20/26
Cardinal Health price target raised to $274 from $260 at UBSCardinal Health price target raised to $274 from $260 at UBS
William O'Neil Analyst forecast on GB:0HTG
Unknown Analyst
William O'Neil
Not Ranked
William O'Neil
―
Buy
―
Initiated
06/12/26
Cardinal Health (CAH) Gets a Buy from William O'Neil
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BTSGBrightSpring Health Services, Inc.
GPCRStructure Therapeutics, Inc. Sponsored ADR
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
JBIOJade Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cardinal Health

3 Months
Elizabeth Anderson CFAEvercore ISI
Success Rate
11/13 ratings generated profit
85%
Average Return
+10.22%
Copying Elizabeth Anderson CFA's trades and holding each position for 3 Months would result in 84.62% of your transactions generating a profit, with an average return of +10.22% per trade.
1 Year
Elizabeth Anderson CFAEvercore ISI
Success Rate
13/13 ratings generated profit
100%
Average Return
+29.79%
Copying Elizabeth Anderson CFA's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +29.79% per trade.
2 Years
Kevin CaliendoUBS
Success Rate
19/19 ratings generated profit
100%
Average Return
+73.07%
Copying Kevin Caliendo's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +73.07% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0HTG Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
17
13
14
16
20
Hold
2
1
1
1
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
19
14
15
17
24
In the current month, 0HTG has received 20 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. 0HTG average Analyst price target in the past 3 months is 270.00.
Each month's total comprises the sum of three months' worth of ratings.

0HTG Financial Forecast

0HTG Earnings Forecast

Next quarter’s earnings estimate for 0HTG is $2.94 with a range of $2.88 to $3.09. The previous quarter’s EPS was $2.91. 0HTG beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0HTG has Performed in-line its overall industry.
Next quarter’s earnings estimate for 0HTG is $2.94 with a range of $2.88 to $3.09. The previous quarter’s EPS was $2.91. 0HTG beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0HTG has Performed in-line its overall industry.

0HTG Sales Forecast

Next quarter’s sales forecast for 0HTG is $66.71B with a range of $65.08B to $67.25B. The previous quarter’s sales results were $63.67B. 0HTG beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0HTG has Performed in-line its overall industry.
Next quarter’s sales forecast for 0HTG is $66.71B with a range of $65.08B to $67.25B. The previous quarter’s sales results were $63.67B. 0HTG beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0HTG has Performed in-line its overall industry.

0HTG Stock Forecast FAQ

What is GB:0HTG’s average 12-month price target, according to analysts?
Based on analyst ratings, Cardinal Health’s 12-month average price target is 270.00.
    What is GB:0HTG’s upside potential, based on the analysts’ average price target?
    Cardinal Health has 17.05% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Cardinal Health a Buy, Sell or Hold?
          Cardinal Health has a consensus rating of Strong Buy, which is based on 13 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Cardinal Health’s share price target?
            The average share price target for Cardinal Health is 270.00. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is $292.00 ,and the lowest forecast is $250.00. The average share price target represents 17.05% Increase from the current price of $230.68.
              What do analysts say about Cardinal Health?
              Cardinal Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.
                How can I buy shares of Cardinal Health?
                To buy shares of GB:0HTG, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.